July 7th, 2026 - 04:29 GMT
Globalpharma, a leading generics manufacturer in the UAE and a wholly owned subsidiary of Dubai Investments PJSC, has reduced its carbon footprint by approximately 11,400 tonnes of CO₂ through the installation of a 612 kWp (kilowatt-peak) rooftop solar photovoltaic (PV) system at its manufacturing facility in Dubai Investments Park (DIP). The system is expected to generate approximately 25.3 GWh (Gigawatt-hour) of clean energy, supporting improved energy efficiency and reduced reliance on grid-supplied electricity. The system was developed in collaboration with 386 Sky Solar Energy Systems LLC, bringing together Globalpharma’s focus ...
